Cargando…
Criteria and Scoring Functions Used in Multi-criteria Decision Analysis and Value Frameworks for the Assessment of Rare Disease Therapies: A Systematic Literature Review
BACKGROUND: Traditionally, the economic value of health technologies is assessed with cost-effectiveness (CE) and budget impact (BI) analyses. However, the evaluation of rare disease therapies often considers novel value criteria. Multi-criteria decision analysis (MCDA) is a promising tool in the as...
Autores principales: | Zelei, Tamás, Mendola, Nicholas D., Elezbawy, Baher, Németh, Bertalan, Campbell, Jonathan D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611126/ https://www.ncbi.nlm.nih.gov/pubmed/34003484 http://dx.doi.org/10.1007/s41669-021-00271-w |
Ejemplares similares
-
Potential Criteria for Frameworks to Support the Evaluation of Innovative Medicines in Upper Middle-Income Countries—A Systematic Literature Review on Value Frameworks and Multi-Criteria Decision Analyses
por: Jakab, Ivett, et al.
Publicado: (2020) -
Development of multi-criteria decision analysis (MCDA) framework for off-patent pharmaceuticals – an application on improving tender decision making in Indonesia
por: Inotai, Andras, et al.
Publicado: (2018) -
A multi-criteria decision analysis (MCDA) tool for purchasing off-patent oncology medicines in Egypt
por: Elezbawy, Baher, et al.
Publicado: (2022) -
Assessing the Preferences for Criteria in Multi-Criteria Decision Analysis in Treatments for Rare Diseases
por: Schey, Carina, et al.
Publicado: (2020) -
Framework for Patient Experience Value Elements in Rare Disease: A Case Study Demonstrating the Applicability of Combined Qualitative and Quantitative Methods
por: McQueen, R. Brett, et al.
Publicado: (2022)